{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T03:23:31Z","timestamp":1790220211617,"version":"4.1.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T00:00:00Z","timestamp":1780876800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"vor","delay-in-days":66,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-08404-7","type":"journal-article","created":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T04:24:54Z","timestamp":1780892694000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["SIRT3 regulates mitochondrial metabolism through deacetylation of SLC25A6 to impact gastric cancer progression and drug resistance"],"prefix":"10.1186","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6780-8720","authenticated-orcid":false,"given":"Wenjun","family":"Meng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunlan","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiadi","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Mu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liansha","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueting","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinqin","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiyan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,8]]},"reference":[{"issue":"3","key":"8404_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clinicians. 2024;74(3):229\u201363. https:\/\/doi.org\/10.3322\/caac.21834.","journal-title":"CA Cancer J Clinicians"},{"issue":"6","key":"8404_CR2","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1136\/gutjnl-2024-333932","volume":"74","author":"Y Song","year":"2025","unstructured":"Song Y, Wang X, Shen Y, Chen L, Yang L, Wang R, et al. Trends and cross-country inequality in the incidence of GI cancers among the working-age population from 1990 to 2021: a Global burden of disease 2021 analysis. Gut. 2025;74(6):948\u201359. https:\/\/doi.org\/10.1136\/gutjnl-2024-333932.","journal-title":"Gut"},{"key":"8404_CR3","doi-asserted-by":"publisher","first-page":"101003","DOI":"10.1016\/j.lanwpc.2023.101003","volume":"44","author":"F He","year":"2024","unstructured":"He F, Wang S, Zheng R, Gu J, Zeng H, Sun K, et al. Trends of gastric cancer burdens attributable to risk factors in China from 2000 to 2050. LancetThe Lancet Reg Health - West Pac. 2024;44:101003. https:\/\/doi.org\/10.1016\/j.lanwpc.2023.101003.","journal-title":"LancetThe Lancet Reg Health - West Pac"},{"issue":"9","key":"8404_CR4","doi-asserted-by":"publisher","first-page":"893","DOI":"10.3390\/bioengineering11090893","volume":"11","author":"WJ Meng","year":"2024","unstructured":"Meng WJ, Guo JM, Huang L, Zhang YY, Zhu YT, Tang LS, et al. Anoikis-related Long non-coding RNA signatures to predict prognosis and immune infiltration of gastric cancer. Bioeng (Basel). 2024;11(9):893. https:\/\/doi.org\/10.3390\/bioengineering11090893.","journal-title":"Bioeng (Basel)"},{"issue":"1","key":"8404_CR5","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13045-023-01451-3","volume":"16","author":"WL Guan","year":"2023","unstructured":"Guan WL, He Y, Xu RH. Gastric cancer treatment: recent progress and future perspectives. J Hematol Oncol. 2023;16(1):57. https:\/\/doi.org\/10.1186\/s13045-023-01451-3.","journal-title":"J Hematol Oncol"},{"issue":"3","key":"8404_CR6","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/s41575-022-00703-w","volume":"20","author":"M Alsina","year":"2023","unstructured":"Alsina M, Arrazubi V, Diez M, Tabernero J. Current developments in gastric cancer: from molecular profiling to treatment strategy. Nat Rev Gastroenterol Hepatol. 2023;20(3):155\u201370. https:\/\/doi.org\/10.1038\/s41575-022-00703-w.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"8404_CR7","doi-asserted-by":"publisher","first-page":"4554","DOI":"10.1038\/s41467-022-32101-w","volume":"13","author":"Y Tan","year":"2022","unstructured":"Tan Y, Li J, Zhao G, Huang KC, Cardenas H, Wang Y, et al. Metabolic reprogramming from glycolysis to fatty acid uptake and beta-oxidation in platinum-resistant cancer cells. Nat Commun. 2022;13(1):4554. https:\/\/doi.org\/10.1038\/s41467-022-32101-w.","journal-title":"Nat Commun"},{"issue":"7","key":"8404_CR8","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1056\/NEJMoa2304194","volume":"389","author":"IK Mellinghoff","year":"2023","unstructured":"Mellinghoff IK, van den Bent MJ, Blumenthal DT, Touat M, Peters KB, Clarke J, et al. Vorasidenib in IDH1- or IDH2-Mutant Low-Grade Glioma. N Engl J Med. 2023;389(7):589\u2013601. https:\/\/doi.org\/10.1056\/NEJMoa2304194.","journal-title":"N Engl J Med"},{"issue":"1","key":"8404_CR9","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s13045-022-01313-4","volume":"15","author":"P Jin","year":"2022","unstructured":"Jin P, Jiang J, Zhou L, Huang Z, Nice EC, Huang C, et al. Mitochondrial adaptation in cancer drug resistance: prevalence, mechanisms, and management. J Hematol Oncol. 2022;15(1):97. https:\/\/doi.org\/10.1186\/s13045-022-01313-4.","journal-title":"J Hematol Oncol"},{"issue":"8","key":"8404_CR10","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.bbabio.2015.04.009","volume":"1847","author":"EM Palmieri","year":"2015","unstructured":"Palmieri EM, Spera I, Menga A, Infantino V, Porcelli V, Iacobazzi V, et al. Castegna A: acetylation of human mitochondrial citrate carrier modulates mitochondrial citrate\/malate exchange activity to sustain NADPH production during macrophage activation. Biochim et Biophys Acta (BBA) - Bioenerg. 2015;1847(8):729\u201338. https:\/\/doi.org\/10.1016\/j.bbabio.2015.04.009.","journal-title":"Biochim et Biophys Acta (BBA) - Bioenerg"},{"key":"8404_CR11","doi-asserted-by":"publisher","first-page":"107996","DOI":"10.1016\/j.phrs.2025.107996","volume":"221","author":"L Niu","year":"2025","unstructured":"Niu L, Kang X, Zheng J, Wu F, Liu S, Hong L, et al. Discovery of KMT5A repressed miR-99b cluster with potential to restore chemotherapy sensitivity in gastric cancer by regulating mitochondrial complex II and affecting OXPHOS. Pharmacological Res. 2025;221:107996. https:\/\/doi.org\/10.1016\/j.phrs.2025.107996.","journal-title":"Pharmacological Res"},{"issue":"6","key":"8404_CR12","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1002\/mc.70111","volume":"65","author":"YT Lee","year":"2026","unstructured":"Lee YT, Lin SH, Yeh KT, Yu KS, Hsu PY, Chan MWY. Prevalence of molecular subtypes of gastric cancer in Taiwan and the impact of high SLC25A22 expression on survival: a single-center experience. Mol Carcinog. 2026;65(6):770\u201376. https:\/\/doi.org\/10.1002\/mc.70111.","journal-title":"Mol Carcinog"},{"key":"8404_CR13","doi-asserted-by":"publisher","unstructured":"Marullo R, Werner E, Degtyareva N, Moore B, Altavilla G, Ramalingam SS, et al. Cisplatin induces a mitochondrial-ROS response that contributes to cytotoxicity depending on mitochondrial redox status and bioenergetic functions. PLoS One. 2013;8(11):e81162. https:\/\/doi.org\/10.1371\/journal.pone.0081162.","DOI":"10.1371\/journal.pone.0081162"},{"key":"8404_CR14","doi-asserted-by":"publisher","first-page":"102666","DOI":"10.1016\/j.sbi.2023.102666","volume":"82","author":"F Fiorentino","year":"2023","unstructured":"Fiorentino F, Mai A, Rotili D. The role of structural biology in the design of sirtuin activators. Curr Opin Struct Biol. 2023;82:102666. https:\/\/doi.org\/10.1016\/j.sbi.2023.102666.","journal-title":"Curr Opin Struct Biol"},{"issue":"2","key":"8404_CR15","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.tips.2023.12.005","volume":"45","author":"J Zhang","year":"2024","unstructured":"Zhang J, Ye J, Zhu S, Han B, Liu B. Context-dependent role of SIRT3 in cancer. Trends Pharmacological Sci. 2024;45(2):173\u201390. https:\/\/doi.org\/10.1016\/j.tips.2023.12.005.","journal-title":"Trends Pharmacological Sci"},{"issue":"5","key":"8404_CR16","doi-asserted-by":"publisher","first-page":"440","DOI":"10.4161\/cam.36224","volume":"8","author":"JEN Jonkman","year":"2014","unstructured":"Jonkman JEN, Cathcart JA, Xu F, Bartolini ME, Amon JE, Stevens KM, et al. An introduction to the wound healing assay using live-cell microscopy. Cell Adh Migr. 2014;8(5):440\u201351. https:\/\/doi.org\/10.4161\/cam.36224.","journal-title":"Cell Adh Migr"},{"key":"8404_CR17","doi-asserted-by":"publisher","unstructured":"Yu FY, Xu Q, Wu DD, Lau ATY, Xu YM. The prognostic and clinicopathological roles of Sirtuin-3 in various cancers. PLoS One. 2016;11(8):e0159801. https:\/\/doi.org\/10.1371\/journal.pone.0159801.","DOI":"10.1371\/journal.pone.0159801"},{"key":"8404_CR18","doi-asserted-by":"publisher","unstructured":"Shi J, Xiong Z, Wang K, Yuan C, Huang Y, Xiao W, et al. HIF2\u03b1 promotes tumour growth in clear cell renal cell carcinoma by increasing the expression of NUDT1 to reduce oxidative stress. Clin Transl Med. 2021;11(11):e592. https:\/\/doi.org\/10.1002\/ctm2.592.","DOI":"10.1002\/ctm2.592"},{"issue":"1","key":"8404_CR19","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s13000-023-01409-6","volume":"18","author":"N Elkady","year":"2023","unstructured":"Elkady N, Aldesoky AI, Dawoud MM. Evaluation of ARK5 and SIRT3 expression in renal cell carcinoma and their clinical significance. Diagn Pathol. 2023;18(1):125. https:\/\/doi.org\/10.1186\/s13000-023-01409-6.","journal-title":"Diagn Pathol"},{"issue":"18","key":"8404_CR20","doi-asserted-by":"publisher","first-page":"5464","DOI":"10.7150\/jca.53173","volume":"12","author":"K Cao","year":"2021","unstructured":"Cao K, Chen Y, Zhao S, Huang Y, Liu T, Liu H, et al. Sirt3 promoted DNA damage repair and radioresistance through ATM-Chk2 in non-small cell lung cancer cells. J Cancer. 2021;12(18):5464\u201372. https:\/\/doi.org\/10.7150\/jca.53173.","journal-title":"J Cancer"},{"issue":"10","key":"8404_CR21","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.1038\/s41388-019-1126-6","volume":"39","author":"PK Neeli","year":"2020","unstructured":"Neeli PK, Gollavilli PN, Mallappa S, Hari SG, Kotamraju S. A novel metadherin\u03947 splice variant enhances triple negative breast cancer aggressiveness by modulating mitochondrial function via NF\u0138B-SIRT3 axis. Oncogene. 2020;39(10):2088\u2013102. https:\/\/doi.org\/10.1038\/s41388-019-1126-6.","journal-title":"Oncogene"},{"issue":"7","key":"8404_CR22","doi-asserted-by":"publisher","first-page":"10431","DOI":"10.18632\/aging.202803","volume":"13","author":"J Zhang","year":"2021","unstructured":"Zhang J, Han L, Yu J, Li H, Li Q. Li Q: miR-224 aggravates cancer-associated fibroblast-induced progression of non-small cell lung cancer by modulating a positive loop of the SIRT3\/AMPK\/mTOR\/HIF-1\u03b1 axis. Aging (Albany NY). 2021;13(7):10431\u201349. https:\/\/doi.org\/10.18632\/aging.202803.","journal-title":"Aging (Albany NY)"},{"key":"8404_CR23","doi-asserted-by":"publisher","first-page":"910963","DOI":"10.3389\/fonc.2022.910963","volume":"12","author":"Q Zhao","year":"2022","unstructured":"Zhao Q, Zhou J, Li F, Guo S, Zhang L, Li J, et al. The role and therapeutic perspectives of Sirtuin 3 in cancer metabolism reprogramming, metastasis, and Chemoresistance. Front Oncol. 2022;12:910963. https:\/\/doi.org\/10.3389\/fonc.2022.910963.","journal-title":"Front Oncol"},{"key":"8404_CR24","doi-asserted-by":"publisher","first-page":"102576","DOI":"10.1016\/j.arr.2024.102576","volume":"102","author":"R Thapa","year":"2024","unstructured":"Thapa R, Gupta S, Gupta G, Bhat AA, Smriti S, Singla M, et al. Epithelial\u2013mesenchymal transition to mitigate age-related progression in lung cancer. Ageing Res Rev. 2024;102:102576. https:\/\/doi.org\/10.1016\/j.arr.2024.102576.","journal-title":"Ageing Res Rev"},{"issue":"7920","key":"8404_CR25","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1038\/s41586-022-04952-2","volume":"607","author":"Y Liu","year":"2022","unstructured":"Liu Y, Qi X, Donnelly L, Elghobashi-Meinhardt N, Long T, Zhou RW, et al. Mechanisms and inhibition of porcupine-mediated Wnt acylation. Nature. 2022;607(7920):816\u201322. https:\/\/doi.org\/10.1038\/s41586-022-04952-2.","journal-title":"Nature"},{"key":"8404_CR26","doi-asserted-by":"publisher","first-page":"116561","DOI":"10.1016\/j.lfs.2019.116561","volume":"232","author":"L Hou","year":"2019","unstructured":"Hou L, Wang R, Wei H, Li S, Liu L, Lu X, et al. ABT737 enhances ovarian cancer cells sensitivity to cisplatin through regulation of mitochondrial fission via Sirt3 activation. Life Sci. 2019;232:116561. https:\/\/doi.org\/10.1016\/j.lfs.2019.116561.","journal-title":"Life Sci"},{"issue":"8","key":"8404_CR27","doi-asserted-by":"publisher","first-page":"6067","DOI":"10.1002\/jcp.26443","volume":"233","author":"M Torrens-Mas","year":"2018","unstructured":"Torrens-Mas M, Hern\u00e1ndez-L\u00f3pez R, Oliver J, Roca P, Sastre-Serra J. Sirtuin 3 silencing improves oxaliplatin efficacy through acetylation of MnSOD in colon cancer. J Cellular Physiol. 2018;233(8):6067\u201376. https:\/\/doi.org\/10.1002\/jcp.26443.","journal-title":"J Cellular Physiol"},{"key":"8404_CR28","doi-asserted-by":"publisher","unstructured":"Chen Y, Fu LL, Wen X, Wang XY, Liu J, Cheng Y, et al. Sirtuin-3 (SIRT3), a therapeutic target with oncogenic and tumor-suppressive function in cancer. Cell Death Dis. 2014;5(2):e 1047. https:\/\/doi.org\/10.1038\/cddis.2014.14.","DOI":"10.1038\/cddis.2014.14"},{"key":"8404_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.biochi.2020.08.021","volume":"179","author":"S Wang","year":"2020","unstructured":"Wang S, Zhang J, Deng X, Zhao Y, Xu K. Advances in characterization of SIRT3 deacetylation targets in mitochondrial function. Biochimie. 2020;179:1\u201313. https:\/\/doi.org\/10.1016\/j.biochi.2020.08.021.","journal-title":"Biochimie"},{"issue":"10","key":"8404_CR30","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1016\/j.bbamem.2008.04.011","volume":"1778","author":"M Klingenberg","year":"2008","unstructured":"Klingenberg M. The ADP and ATP transport in mitochondria and its carrier. Biochim et Biophys Acta (BBA) - Biomembr. 2008;1778(10):1978\u20132021. https:\/\/doi.org\/10.1016\/j.bbamem.2008.04.011.","journal-title":"Biochim et Biophys Acta (BBA) - Biomembr"},{"issue":"2\u20133","key":"8404_CR31","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.mam.2012.05.006","volume":"34","author":"B Cl\u00e9men\u00e7on","year":"2013","unstructured":"Cl\u00e9men\u00e7on B, Babot M, Tr\u00e9z\u00e9guet V. The mitochondrial ADP\/ATP carrier (SLC25 family): pathological implications of its dysfunction. Mol Aspects Med. 2013;34(2\u20133):485\u201393. https:\/\/doi.org\/10.1016\/j.mam.2012.05.006.","journal-title":"Mol Aspects Med"},{"issue":"1","key":"8404_CR32","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3390\/biom11010038","volume":"11","author":"L Trisolini","year":"2020","unstructured":"Trisolini L, Laera L, Favia M, Muscella A, Castegna A, Pesce V, et al. Differential expression of ADP\/ATP carriers as a biomarker of metabolic remodeling and survival in kidney cancers. Biomolecules. 2020;11(1):38. https:\/\/doi.org\/10.3390\/biom11010038.","journal-title":"Biomolecules"},{"issue":"1","key":"8404_CR33","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s12967-025-07505-z","volume":"24","author":"P D\u2019Addabbo","year":"2025","unstructured":"D\u2019Addabbo P, De Grassi A, De Luca DI, Scaglione V, Francavilla AL, Todisco S, et al. SLC25A mitochondrial carriers as biomarkers and therapeutic targets of spaceflight-induced dysfunction: the ADP\/ATP carrier (AAC3) as a structural case study. J Transl Med. 2025;24(1):101. https:\/\/doi.org\/10.1186\/s12967-025-07505-z.","journal-title":"J Transl Med"},{"key":"8404_CR34","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.bcp.2015.11.019","volume":"100","author":"S Todisco","year":"2016","unstructured":"Todisco S, Di Noia MA, Onofrio A, Parisi G, Punzi G, Redavid G, et al. Identification of new highly selective inhibitors of the human ADP\/ATP carriers by molecular docking and in vitro transport assays. Biochemical Pharmacol. 2016;100:112\u201332. https:\/\/doi.org\/10.1016\/j.bcp.2015.11.019.","journal-title":"Biochemical Pharmacol"},{"issue":"2","key":"8404_CR35","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/cdd.2017.144","volume":"25","author":"J Gao","year":"2018","unstructured":"Gao J, Feng Z, Wang X, Zeng M, Liu J, Han S, et al. SIRT3\/SOD2 maintains osteoblast differentiation and bone formation by regulating mitochondrial stress. Cell Death Differ. 2018;25(2):229\u201340. https:\/\/doi.org\/10.1038\/cdd.2017.144.","journal-title":"Cell Death Differ"},{"issue":"19","key":"8404_CR36","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1161\/CIRCULATIONAHA.117.030486","volume":"137","author":"X Zhang","year":"2018","unstructured":"Zhang X, Ji R, Liao X, Castillero E, Kennel PJ, Brunjes DL, et al. MicroRNA-195 regulates metabolism in failing myocardium via alterations in Sirtuin 3 expression and mitochondrial protein acetylation. Circulation. 2018;137(19):2052\u201367. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.117.030486.","journal-title":"Circulation"},{"key":"8404_CR37","doi-asserted-by":"publisher","unstructured":"Zhu S, Liu F, Chen X, Xia S, Wu Y, Tang W, et al. Inter-organelle communication dynamically orchestrates juvenile hormone biosynthesis and female reproduction. Natl Sci Rev. 2025;12(3):nwaf022. https:\/\/doi.org\/10.1093\/nsr\/nwaf022.","DOI":"10.1093\/nsr\/nwaf022"},{"issue":"17","key":"8404_CR38","doi-asserted-by":"publisher","first-page":"14078","DOI":"10.1074\/jbc.M112.355206","volume":"287","author":"W Yu","year":"2012","unstructured":"Yu W, Dittenhafer-Reed KE, Denu JM. SIRT3 protein deacetylates isocitrate dehydrogenase 2 (IDH2) and regulates mitochondrial redox status. J Biol Chem. 2012;287(17):14078\u201386. https:\/\/doi.org\/10.1074\/jbc.M112.355206.","journal-title":"J Biol Chem"},{"key":"8404_CR39","doi-asserted-by":"publisher","unstructured":"Bround MJ, Havens JR, York AJ, Sargent MA, Karch J, Molkentin JD. ANT-dependent MPTP underlies necrotic myofiber death in muscular dystrophy. Sci Adv. 2023;9(34):eadi 2767. https:\/\/doi.org\/10.1126\/sciadv.adi2767.","DOI":"10.1126\/sciadv.adi2767"},{"key":"8404_CR40","doi-asserted-by":"publisher","unstructured":"Desousa BR, Kim KK, Jones AE, Ball AB, Hsieh WY, Swain P, et al. Calculation of ATP production rates using the Seahorse XF analyzer. EMBO Rep. 2023;24(10):e56380. https:\/\/doi.org\/10.15252\/embr.202256380.","DOI":"10.15252\/embr.202256380"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08404-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08404-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08404-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T03:44:42Z","timestamp":1786592682000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-08404-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,8]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8404"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-08404-7","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,8]]},"assertion":[{"value":"7 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study involves human participants and animals and was approved by the Institutional Review Board of West China Hospital. All animal experiments were conducted in accordance with the National Institutes of Health (NIH) Guide for the Care and Use of Laboratory Animals. This study involving human participants was conducted in accordance with the Declaration of Helsinki. The informed consent has been obtained directly from the patients and the families. Participants gave informed consent to participate in the study before taking part.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1045"}}